Mehow Innovative Ltd
SZSE:301363
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
M
|
Mehow Innovative Ltd
SZSE:301363
|
19.8B CNY |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.1B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
176.3B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
145.4B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
125.2B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
111.5B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.2B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.8B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.9B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Mehow Innovative Ltd
Glance View
Nestled in the nexus of China's thriving manufacturing sector, Mehow Innovative Ltd. emerged as a beacon of ingenuity in medical device manufacturing. Founded in 2005, the company has harnessed its expertise in precision engineering and cutting-edge technology to create an array of medical devices that improve patient care across global markets. Specializing in research, development, and production, Mehow Innovative has established itself as a pivotal player, fusing sophisticated technology with practical application. Its manufacturing prowess, centered in Shenzhen, benefits from China's robust supply chains and skilled workforce, enabling the company to produce cost-effective and high-quality medical solutions. Revenue for Mehow Innovative Ltd. flows from its strategic focus on the ODM (Original Design Manufacturer) and OEM (Original Equipment Manufacturer) segments, serving an array of clients who rely on the company’s ability to deliver tailored solutions. By partnering with leading healthcare firms, Mehow ensures a steady stream of business, offering customized product development that spans diagnostic, therapeutic, and monitoring devices. Furthermore, its commitment to stringent quality standards and compliance with international certifications fortifies its position in the competitive landscape, ensuring the trust and loyalty of a wide client base. Through innovation and reliability, Mehow not only survives but thrives in the ever-evolving arena of medical device manufacturing, leaving its mark on healthcare systems worldwide.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Mehow Innovative Ltd is 19.2%, which is below its 3-year median of 22.9%.
Over the last 3 years, Mehow Innovative Ltd’s Net Margin has decreased from 29.1% to 19.2%. During this period, it reached a low of 18.7% on Sep 30, 2024 and a high of 30.6% on Jun 30, 2023.